An observational study in Infant Formula, sponsored by Mead Johnson Nutrition. Completed at 17 sites in France. Open to participants aged 6 Months to 36 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-30.
Sponsored by Mead Johnson Nutrition (part of Reckitt) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest.
The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest. Secondary objectives are to describe the modalities of feeding before, during and after consuming the RIF, to describe the growth of children who have consumed a RIF for at least 1 month, on the basis of anthropometric data collected during the first year of life. As a second intention, this study also aims to monitor the evolution of child's digestive and allergic symptoms, if any, and the sociodemographic characteristics of the infant's family.
Mead Johnson Nutrition is the lead sponsor of 58 studies on the registry; 1 is open to participants now.
First submitted after Mead Johnson Nutrition became part of Reckitt.
Counted across the registry records on this site, refreshed daily.
120 infants will be recruited for this study, according to the following inclusion and non-inclusion criteria, including at least 60 infants who started the RIF before the age of 6 months.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After inclusion (V1), infants will return for a V2 visit at 12 months (± 30 days) of age (according to the child's regular appointment calendar). No visit is imposed by the protocol. Anthropometric data from visits to the pediatrician carried out between V1 and V2 will be collected from medical records, as well as the date of cessation of RIF, if applicable. Retrospective data will be collected from medical files (anthropometric data, medical and feeding history) and from parents' and investigator's recall.
Other: Rice infant formula
After inclusion (V1), infants will return for a V2 visit at 12 months (± 30 days) of age (according to the child's regular appointment calendar). No visit is imposed by the protocol. Anthropometric data from visits to the pediatrician carried out between V1 and V2 will be collected from medical records, as well as the date of cessation of RIF, if applicable. Retrospective data will be collected from medical files (anthropometric data, medical and feeding history) and from parents' and investigator's recall.
Other: Rice infant formula
Any commercially available rice infant formula whom the pediatrician has previously deemed, or is deeming it useful to consume.
Questionnaire - reason for prescribing a RIF during the 1st year of life.
The main objective is to describe the main reason for prescribing a RIF by the pediatrician during the 1st year of life.
Time frame: 1 to 7 months
Questionnaire - Reason for prescribing a RIF in first 6 months of life
o describe the main reason for prescribing a RIF by the pediatrician during the 1st 6 months of life.
Time frame: up to 365 days of age
Questionnaire - Diet characteristics
To describe the conditions of RIF consumption during the follow-up, and the other main characteristics of the diet.
Time frame: up to 365 days of age
Growth z-scores body mass index (BMI)-for-age
body mass index (BMI)-for-age
Time frame: up to 365 days of age
Growth z-score
Weight-for-age z-score
Time frame: up to 365 days of age
Growth z-score
Length/Height-for-age z-score
Time frame: up to 365 days of age
Growth z-score
Weight-for-length/height z-score
Time frame: up to 365 days of age
Growth z-score
Head circumference-for-age z-score
Time frame: up to 365 days of age
Questionnaire - Evolution of digestive and allergic symptoms
To describe the evolution of digestive and allergic symptoms during follow-up.
Time frame: up to 365 days of age
Socio-demographic characteristics
To describe the socio-demographic characteristics of the infants' families
Time frame: up to 365 days of age
Plan to share: No
No publications or documents are linked to this record.
Ran from Mar 2024 to primary completion in Oct 2025, 19 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.